ClinicalTrials.Veeva

Menu

Ketamine Gargle for Pain After Pediatric Tonsillectomy (KET-TONSIL)

H

Hospital Universitario de Caracas

Status and phase

Completed
Phase 4

Conditions

Adenotonsillectomy
Postoperative Pain
Tonsillectomy

Treatments

Other: Normal Saline (0.9% NaCl)
Drug: Ketamine Hydrochloride in saline

Study type

Interventional

Funder types

Other

Identifiers

NCT07558044
KET-AT-2024-01

Details and patient eligibility

About

Post-tonsillectomy pain in children is a common and clinically significant problem that may lead to poor oral intake, dehydration, and delayed recovery. This study evaluates whether a simple preoperative intervention-gargling with ketamine-can reduce postoperative pain and improve recovery after pediatric adenotonsillectomy.

In this randomized, double-blind, placebo-controlled trial, 420 children aged 4 to 12 years undergoing elective adenotonsillectomy were assigned to receive either a ketamine gargle (40 mg in saline) or a saline placebo prior to anesthesia induction. Pain intensity was measured using the Visual Analog Scale at multiple time points within the first 24 hours after surgery. Secondary outcomes included postoperative bleeding requiring reintervention, analgesic consumption, and adverse events.

The study aims to determine whether topical ketamine provides effective and safe analgesia as part of an opioid-sparing strategy in pediatric airway surgery.

Full description

Adenotonsillectomy is one of the most frequently performed surgical procedures in pediatric patients and is associated with significant postoperative pain. Effective analgesia remains challenging due to the need to balance efficacy with safety, particularly avoiding opioid-related respiratory complications. Topical ketamine, a non-competitive NMDA receptor antagonist, has been proposed as a peripheral analgesic strategy capable of reducing nociceptive signaling without significant systemic effects.

This study was designed as a prospective, randomized, double-blind, placebo-controlled trial conducted at a tertiary care center. A total of 420 pediatric patients (ASA I-II, aged 4-12 years) scheduled for elective adenotonsillectomy were enrolled. Participants were randomized in a 1:1 ratio to receive either a ketamine gargle (40 mg diluted in 30 mL saline) or a placebo saline gargle administered 5 minutes before induction of anesthesia.

All patients underwent standardized anesthetic and surgical protocols to minimize confounding variables. Pain intensity was assessed using the Visual Analog Scale at 0, 4, 8, 12, and 24 hours postoperatively. Secondary outcomes included incidence of postoperative hemorrhage requiring surgical reintervention, total rescue analgesic consumption, and adverse events such as nausea, vomiting, sedation, or psychomimetic effects.

The primary objective was to evaluate the analgesic efficacy of preemptive topical ketamine. Secondary analyses explored its potential impact on postoperative morbidity, particularly bleeding events. This study was conducted in accordance with ethical standards and CONSORT guidelines.

Enrollment

420 patients

Sex

All

Ages

4 to 12 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • Children aged 4-12 years
  • ASA physical status I-II
  • Scheduled for elective adenotonsillectomy
  • Ability to gargle and spit the study solution

Exclusion criteria

  • Known hypersensitivity to ketamine
  • Coagulation disorders
  • History of neuropsychiatric disease
  • Active upper respiratory tract infection

Exclusion Criteria:

-

Trial design

Primary purpose

Treatment

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Quadruple Blind

420 participants in 2 patient groups

KETAMINE GROUP
Experimental group
Description:
Preoperative gargle with 40 mg ketamine diluted in 30 mL saline, administered 5 minutes before induction of anesthesia.
Treatment:
Drug: Ketamine Hydrochloride in saline
Other: Normal Saline (0.9% NaCl)
PLACEBO GROUP
Experimental group
Description:
Preoperative gargle with 30 mL normal saline administered 5 minutes before induction.
Treatment:
Drug: Ketamine Hydrochloride in saline
Other: Normal Saline (0.9% NaCl)

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems